Mangoceuticals Inc. (NASDAQ:MGRX) is the subject of renewed investor interest depicted by a high turnover in traded shares as it sends shockwaves in the multi-billion men’s health and wellness segment. Focused on developing various men’s products and selling through a secure telemedicine platform, the company is staring at tremendous opportunities in the $30 billion market, growing at a compound annual growth rate of 15%.
Mango ED Product Line
Mango is the proprietary special formulation that has strengthened the company’s edge in the men’s health and wellness segment. Formulated using food and drug administration-approved compounds designed to ensure men achieve optimum intimate performance, Mango is proving to be the product to beat in the highly lucrative industry.
Tadalafil is the company’s lead product under the Mango brand, containing the same ingredient found in Cialis. In addition, it contains Oxytocin and L Arginine, which makes it highly effective in addressing any form of personal dysfunction in men. The prescription medication is currently available for use upon prescription by a physician.
In addition to Tadalafil, Mangoceuticals has moved to strengthen its prospects in the multibillion-dollar men’s health and wellness segment with another product under the Mango brand. Sildenafil-based mango-based will be the new product poised for sale in the summer.
Sildenafil and Tadalafil Edge
The Sildenafil-based mango ED product should be available online as Mangoceuticals becomes a legitimate competitor in the men’s health and wellness segment. While Sildenafil and Tadalafil are biotech solutions, they come with unique features making them ideal for different situations.
For starters, Tadalafil would be prescribed to men looking to last longer in their intimate escapades, while Sildenafil would be prescribed to men looking to reach full efficacy faster. Both options should allow the company to capture additional market share and not exclude customers based on preference.
Going to Mass Market
Mangoceuticals has been flying high in the market owing to an aggressive marketing campaign that is increasingly taking the Mango ED product line to the mass market. The buzz and hype generated through the expanded marketing activities stand to strengthen the company’s push for loyal customers and new revenue streams.
The stock was on a roll on July 27, 2023, after the company announced a new exclusive sponsorship deal with ITS Media. Under the terms of the agreement, the company, through its mango product, is to sponsor the popular Pillow Talk podcast.
The podcast boasts an enormous social media footprint with over 36 million accounts reached on Instagram and 25 million views on Tik Tok provides a perfect marketing platform for reaching the desired audience. According to Mangoceuticals CEO Jacob Cohen, the strategic partnership with the team at Pillow Talk offers an exciting opportunity for connecting with the desired demographic.
The Pillow Talk deal builds on a similar marketing sponsorship deal that Mangoceuticals inked with Adam22 on July 18, 2023, to be the exclusive new sponsor of the No Jumper and Plug Talk episodes. The sponsorship deal, which starts in August, paves the way for Mangoceuticals to target the over 12 million followers that listen to the No Jumper and Plug Talk podcasts.
The fact that over 90% of the nearly 12 million followers on various social networks are male presents a perfect target audience that Mangoceuticals can tap into. Mango ED product will be the exclusive sponsor of 8 episodes of ten NO Jumper episodes and 2 episodes of the Plug Talk with more brand involvement in the works.
The two sponsorship deals come on the heels of Mangoceuticals inking a strategic marketing deal with GaS Digital Network. The deal paves the way for the company to market its Mango ED product across various hardcore podcasts. GaS Digital Network has already committed to generating over 1 million unique impressions over the next two months as one of the ways of popularizing the brand.
On June 8, 2023, Mangoceuticals also confirmed it had been engaged as the new sponsor of the Barstool Sports Only Stan’s podcasts, affirming its acceptance in the industry. By sponsoring the Only Stan’s podcast, Mangoceuticals stands to target over 300,000 listeners per episode.
The Barstool and GaS digital sponsorship deals have the potential to generate substantial new interest among customers and prospective investors. Additionally, they are expected to lead to new loyal customers that should help strengthen the company’s recurring revenue base.
MGRX a Rising Star
There is no doubt that Mangoceuticals is a rising star in the men’s health and wellness segment, worth over $30 billion and growing. Its unique angle in the market with proven products with FDA-approved compounds underscores why it is a rising brand in the segment. This might explain why the stock has been flying high under the radar.
Please make sure to read and completely understand our disclaimer at InvestorBrandMedia.com/Disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. InvestorBrandMedia.com strongly recommends you consult a licensed or registered professional before making any investment decision. Neither InvestorBrandMedia.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. InvestorBrandMedia.com often gets compensated for advertisement services that are disclosed on our disclaimer located at InvestorBrandMedia.com/Disclaimer.
